TE_6044
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | -, CCNT2-AS1 |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 181.14 |
| Counts of samples | TCGA_tumor:1124; TCGA_normal:6; GTEx:0 |
| TSS | chr2(-):134825832 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_6044.1 | CCNT2-AS1 | Chimeric | Non-coding | Non-coding | chr2(-):134804723,134804743,134810921,134811279,134825706,134825833 |
| teRNA_6044.2 | CCNT2-AS1 | Chimeric | Non-coding | Non-coding | chr2(-):134804723,134804743,134810921,134811279,134825791,134825833 |
| teRNA_6044.3 | - | Intergenic | Non-coding | Non-coding | chr2(-):134795306,134795326,134825281,134825560,134825706,134825833 |
| teRNA_6044.4 | CCNT2-AS1 | Chimeric | Non-coding | Non-coding | chr2(-):134804723,134804743,134810921,134811279,134825281,134825560,134825706,134825833 |
| teRNA_6044.5 | - | Intergenic | Non-coding | Non-coding | chr2(-):134824653,134824673,134825281,134825560,134825706,134825833 |
| teRNA_6044.6 | - | Intergenic | Non-coding | Non-coding | chr2(-):134794281,134794301,134825281,134825560,134825706,134825833 |
| teRNA_6044.7 | CCNT2-AS1 | Chimeric | Non-coding | Non-coding | chr2(-):134804723,134804743,134825281,134825560,134825706,134825833 |
| teRNA_6044.8 | - | Intergenic | Non-coding | Non-coding | chr2(-):134811646,134811666,134825281,134825560,134825706,134825833 |
| teRNA_6044.9 | CCNT2-AS1 | Chimeric | Non-coding | Non-coding | chr2(-):134804723,134804743,134810921,134811287,134825706,134825833 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
